Latest Period
Q1 2026
Security Snapshot
Envoy Medical, Inc. - Class A Common Stock (COCH) Institutional Ownership
CUSIP: 29415V109
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
33
Shares (Excl. Options)
17,290,374
Price
$0.67
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock
- Symbol
- COCH on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 17,290,374
- Total 13F value
- $11,499,787
- Portfolio coverage rank
- 0%
- Share change
- +15,048,328
- Value change
- +$10,009,654
- Number of holders
- 33
- Shares outstanding
- 81,261,337
- SEC-reported price per share
- $0.66
- Insider filing price
- $0.66
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- COCH - Envoy Medical, Inc. - Class A Common Stock is tracked under CUSIP 29415V109.
- 33 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 26 to 33 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $982,984 to $11,499,787.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 33 institutions filings for Q1 2026.
Security key
29415V109
Latest holder period
Q1 2026
13F holders
33
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
COCH full holder history
Envoy Medical, Inc. SEC filings
Envoy Medical, Inc. company facts
Envoy Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29415V109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
COCH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TAYLOR GLEN A | 85% | +92% | $47,547,634 | +$37,432,500 | 68,909,614 | +370% | Glen A. Taylor | 12 Feb 2026 |
| Anzu SPAC GP I LLC | 11% | $3,806,377 | 2,718,841 | Anzu SPAC GP I LLC | 29 Sep 2023 | |||
| Ayrton Capital LLC | 7.9% | $1,695,994 | 2,457,963 | Ayrton Capital LLC | 31 Dec 2025 |
As of 31 Mar 2026, 33 institutional investors reported holding 17,290,374 shares of Envoy Medical, Inc. - Class A Common Stock (COCH). This represents 21% of the company’s total 81,261,337 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
21%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.4% | 7,650,000 | 0.32% | $5,088,015 | |
| Bleichroeder LP | 7.7% | 6,250,000 | 0.72% | $4,156,875 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1% | 881,672 | 0% | 0% | $586,312 |
| DSG Capital Advisors, LLC | 0.77% | 625,000 | 0.07% | $415,688 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.64% | 521,824 | +431% | 0% | $347,083 |
| VANGUARD FIDUCIARY TRUST CO | 0.36% | 294,721 | 0% | 0% | $195,989 |
| Focus Partners Wealth | 0.26% | 212,655 | 0% | 0% | $141,437 |
| Arcus Capital Partners, LLC | 0.23% | 187,573 | 0% | 0.04% | $124,755 |
| NORTHERN TRUST CORP | 0.14% | 111,050 | 0% | $73,859 | |
| CIBC Bancorp USA Inc. | 0.1% | 77,887 | 0% | $51,803 | |
| MORGAN STANLEY | 0.09% | 73,900 | +29% | 0% | $49,151 |
| UBS Group AG | 0.09% | 70,459 | +177% | 0% | $46,855 |
| BlackRock, Inc. | 0.06% | 47,514 | +19% | 0% | $31,601 |
| GOLDMAN SACHS GROUP INC | 0.04% | 36,462 | 0% | $24,251 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | 35,297 | -70% | 0% | $23,476 |
| Lantern Wealth Advisors, LLC | 0.04% | 30,000 | 0.01% | $19,953 | |
| LPL Financial LLC | 0.03% | 28,401 | 0% | 0% | $18,890 |
| METEORA CAPITAL, LLC | 0.03% | 28,051 | 0% | 0% | $18,657 |
| STATE STREET CORP | 0.03% | 23,872 | 0% | 0% | $15,877 |
| TWO SIGMA SECURITIES, LLC | 0.03% | 23,121 | -16% | 0% | $15,378 |
| CWM, LLC | 0.02% | 16,500 | 0% | $10,974 | |
| GSA CAPITAL PARTNERS LLP | 0.02% | 12,629 | 0% | $8,000 | |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 0.01% | 12,000 | 0.01% | $8,460 | |
| BlueStem Wealth Partners, LLC | 0.01% | 10,454 | 0% | 0% | $6,953 |
| Ballew Advisors, Inc | 0.01% | 10,121 | 0% | 0% | $6,598 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 17,290,374 | $11,499,787 | +$10,009,654 | $0.67 | 33 |
| 2025 Q4 | 1,486,837 | $982,984 | -$542,227 | $0.66 | 26 |
| 2025 Q3 | 2,123,532 | $1,649,025 | -$138,312 | $0.78 | 28 |
| 2025 Q2 | 2,306,452 | $3,275,197 | +$4,340 | $1.42 | 22 |
| 2025 Q1 | 2,303,397 | $2,998,325 | +$429,096 | $1.30 | 22 |
| 2024 Q4 | 2,015,076 | $2,945,656 | +$1,123,694 | $1.43 | 24 |
| 2024 Q3 | 1,032,950 | $3,330,106 | -$247,608 | $3.25 | 18 |
| 2024 Q2 | 1,162,015 | $2,742,612 | -$97,854 | $2.36 | 20 |
| 2024 Q1 | 1,173,098 | $4,593,072 | -$721,402 | $3.92 | 16 |
| 2023 Q4 | 1,646,603 | $3,013,128 | +$3,013,128 | $1.81 | 9 |